A randomised trial to evaluate the toxicity and efficacy of 1200mg and 1800mg rifampicin daily for four months in the treatment of pulmonary tuberculosis

This website will not work correctly in Internet Explorer 11 and it is strongly recommended that you upgrade to an up-to-date browser. Internet Explorer 11 will go out of support and be retired on June 15, 2022. For more information on upgrading please see browser-update.org.